Literature DB >> 26215688

Kidney cancer: Novel targets in altered tumour metabolism in kidney cancer.

Denise R Minton1, David M Nanus2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26215688     DOI： 10.1038/nrurol.2015.168

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

Review 1.  The genetic basis of kidney cancer: a metabolic disease.

Authors:  W Marston Linehan; Ramaprasad Srinivasan; Laura S Schmidt
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

Review 2.  Glutamine addiction: a new therapeutic target in cancer.

Authors:  David R Wise; Craig B Thompson
Journal:  Trends Biochem Sci       Date:  2010-08       Impact factor: 13.807

3.  Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α.

Authors:  Leiping Fu; Gang Wang; Maria M Shevchuk; David M Nanus; Lorraine J Gudas
Journal:  Cancer Res       Date:  2011-09-09       Impact factor: 12.701

4.  Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.

Authors:  Hiromi I Wettersten; A Ari Hakimi; Dexter Morin; Cristina Bianchi; Megan E Johnstone; Dallas R Donohoe; Josephine F Trott; Omran Abu Aboud; Steven Stirdivant; Bruce Neri; Robert Wolfert; Benjamin Stewart; Roberto Perego; James J Hsieh; Robert H Weiss
Journal:  Cancer Res       Date:  2015-05-07       Impact factor: 12.701

5.  In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation.

Authors:  Paulo A Gameiro; Juanjuan Yang; Ana M Metelo; Rocio Pérez-Carro; Rania Baker; Zongwei Wang; Alexandra Arreola; W Kimryn Rathmell; Aria Olumi; Pilar López-Larrubia; Gregory Stephanopoulos; Othon Iliopoulos
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

6.  Cancer cell metabolism: Warburg and beyond.

Authors:  Peggy P Hsu; David M Sabatini
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

7.  Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability.

Authors:  David R Wise; Patrick S Ward; Jessica E S Shay; Justin R Cross; Joshua J Gruber; Uma M Sachdeva; Jesse M Platt; Raymond G DeMatteo; M Celeste Simon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 12.779

8.  Comprehensive molecular characterization of clear cell renal cell carcinoma.

Authors: 
Journal:  Nature       Date:  2013-06-23       Impact factor: 49.962

Review 9.  Targeting glucose metabolism for cancer therapy.

Authors:  Robert B Hamanaka; Navdeep S Chandel
Journal:  J Exp Med       Date:  2012-02-13       Impact factor: 14.307

10.  Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma.

Authors:  Denise R Minton; Leiping Fu; Qiuying Chen; Brian D Robinson; Steven S Gross; David M Nanus; Lorraine J Gudas
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240
  10 in total
  2 in total

Review 1.  The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Authors:  Susie L Hu; Anthony Chang; Mark A Perazella; Mark D Okusa; Edgar A Jaimes; Robert H Weiss
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

2.  Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma.

Authors:  Kristian B Laursen; Qiuying Chen; Francesca Khani; Nabeel Attarwala; Steve S Gross; Lukas Dow; David M Nanus; Lorraine J Gudas
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.